货号:A722708
同义名:
KB-R7943 (mesylate)
KB-R7943 Mesylate is a potent and selective inhibitor used to reverse mode of the Na+/Ca2+ exchanger with IC50 value of 0.7 μM. It also inhibits the mitochondrial Ca2+ uniporter with IC50 value of 5.5 μM.


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | KB-R7943 mesylate is a widely used inhibitor of the reverse Na+/Ca2+ exchanger (NCXrev) with IC50 of 5.7±2.1 µM. KB-R7943 mesylate induces cancer cell death via activating the JNK pathway and blocking autophagic flux. KB-R7943 mesylate blocks NMDAR-mediated ion currents, and inhibits NMDA-induced increase in cytosolic Ca2+ with IC50=13.4±3.6 µM but accelerates calcium deregulation and mitochondrial depolarization in glutamate-treated neurons. KB-R7943 depolarizes mitochondria in a Ca2+-independent manner. KB-R7943 inhibits 2,4-dinitrophenol-stimulated respiration of cultured neurons with IC50=11.4±2.4 µM. In addition to NCXrev, KB-R7943 dose-dependently and reversibly blocked ion currents elicited by NMDA. KB-R7943 dose-dependently inhibits NMDA-induced increases in [Ca2+]c with IC50=13.4±3.6 µM confirming the inhibition of NMDA receptors observed in electrophysiological experiments[3]. wtRyR1-HEK 293 pretreated with KB-R7943 (10 μM, 10 min) dissolved in the bulk perfusion exhibited significantly attenuated responses to caffeine. In this regard, KB-R7943 produced more pronounced inhibition of caffeine-induced Ca2+ release elicited by 1 mM compared with 0.5 and 0.75 mM (60 versus 58 versus 37%, p<0.05, respectively)[4]. KB-R7943 inhibits both IhERG and native IKr rapidly on membrane depolarization with IC50 values of ~89 and ~120 nM, respectively, for current tails at −40 mV following depolarizing voltage commands to +20 mV. IhERG inhibition by KB-R7943 exhibits both time- and voltage-dependence but shows no preference for inactivated over activated channels[5]. In fish cardiomyocytes IKATP was blocked by KB-R7943 with an IC50 value of 3.14×10(-7) M, while in mammalian cells IC50 was 2.8×10(-6) M (P<0.05). 10(-5) M KB-R7943 inhibited CCCP-induced IKATP by 99.9±0.13% and 97.5±1.2% in crucian carp and mouse ventricular myocytes, respectively[6]. |
| Concentration | Treated Time | Description | References | |
| WT atrial myocytes | 1 µM | Heart Rhythm. 2018 Aug;15(8):1233-1241 | ||
| human embryonic stem cells (H9 and H7) | 100 µmol/L | KB-R7943, as an NCX inhibitor, induced rapid Ca2+ transients in both H9 and H7 human embryonic stem cells, indicating the functional role of NCX in hESCs. | Acta Pharmacol Sin. 2017 Dec;38(12):1663-1672 | |
| porcine retinal venules | 10 μmol/L | 30 minutes | KB-R7943 inhibited the hyperglycemia-enhanced constriction of retinal venules to ET-1, U46619, and norepinephrine. | Diabetes. 2019 Aug;68(8):1624-1634 |
| Pak1−/− atrial myocytes | 1 µM | 15 minutes | KB-R7943 attenuated the AngII-induced increase in diastolic [Ca2+]i and Ca2+ transient amplitude in Pak1−/− cells | Heart Rhythm. 2018 Aug;15(8):1233-1241 |
| human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) | 3 µM or 10 µM | 4-5 minutes | KB-R7943 blocked the arrhythmias caused by -AA+YWF treatment, indicating the role of NCX reverse mode in arrhythmogenesis. | Int J Mol Sci. 2024 Apr 30;25(9):4932 |
| Paediatric glioblastoma cell line SF188 | 0.1–100 μM | 72 hours | KB-R7943 inhibited the viability of SF188 cells in a dose-dependent manner. | Br J Pharmacol. 2019 Aug;176(15):2691-2707 |
| Human glioblastoma cell line U251 | 0.1–100 μM | 72 hours | KB-R7943 inhibited the viability of U251 cells, reducing it to 50–60%, 7–18%, and 2–3% of control level at 20, 50, and 100 μM concentrations, respectively. | Br J Pharmacol. 2019 Aug;176(15):2691-2707 |
| Administration | Dosage | Frequency | Description | References | ||
| Rats | Neonatal monosodium glutamate (MSG)-treated rat model | Intracerebroventricular injection | 62.5 pmol | Single administration | To evaluate the control effect of KB-R7943 on 4-aminopyridine (4-AP)-induced epileptiform activity. Results showed that KB-R7943 significantly reduced 4-AP-induced epileptiform activity in MSG-treated rats. | J Biomed Sci. 2017 May 9;24(1):27 |
| Rat | Isolated rat heart ischemia/reperfusion injury model | Perfusion | 10 μM | 1 min before and 3-min throughout the Ca2+-free solution perfusion, as well as 3 min after restoring normal KH solution | KB-R7943 alleviated heart injury and calpain activity | Cell Death Dis. 2020 May 21;11(5):388 |
| Pigs | Streptozotocin-induced diabetes model | Extraluminal pretreatment | 10 μmol/L | Single treatment, lasting at least 30 minutes | KB-R7943 inhibited the hyperglycemia-enhanced constriction of retinal venules to ET-1, U46619, and norepinephrine. | Diabetes. 2019 Aug;68(8):1624-1634 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.34mL 0.47mL 0.23mL |
11.70mL 2.34mL 1.17mL |
23.39mL 4.68mL 2.34mL |
|
| CAS号 | 182004-65-5 |
| 分子式 | C17H21N3O6S2 |
| 分子量 | 427.5 |
| SMILES Code | NC(SCCC1=CC=C(OCC2=CC=C([N+]([O-])=O)C=C2)C=C1)=N.CS(=O)(O)=O |
| MDL No. | MFCD00952138 |
| 别名 | KB-R7943 (mesylate) |
| 运输 | 蓝冰 |
| InChI Key | WGIKEBHIKKWJLG-UHFFFAOYSA-N |
| Pubchem ID | 9823846 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(245.62 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1